Lymphoma

5 currently open clinical trials
Trial with the ATR Inhibitor BAY-1895344 in Patients with advanced solid Tumors and Lymphomas (first use in humans)
SAKK 69/17
Randomized phase II trial on fitness- and comorbidity- tailored treatment in elderly patients with newly diagnosed Primary CNS Lymphoma
IELSG-45
Phase II study of combination ibrutinib and rituximab in untreated marginal zone lymphomas
IELSG-47
Alternative chemotherapy regimen for patients with Hodgkin lymphoma
HD 21
Optimization of chemotherapy for Burkitt lymphoma
HOVON 127/ SAKK 37/16
All cancer types